New Hampshire Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 9 (90% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 2,496
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 32.67%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 223
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 16.06%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 44.83% 51.57%
White, Hispanic/Latino Patients 12.78% 6.73%
Black/African American, Non-Hispanic/Latino Patients 3.21% 0.45%
Black/African American, Hispanic/Latino Patients 0.64% 0.90%
Asian Patients3 2.04% 0.90%
American Indian/Alaska Native Patients3 0.24% 0.45%
Native Hawaiian/Other Pacific Islander Patients3 0.48% 0.00%
Patients with More than one race3 1.44% 0.45%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.92% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.65% 2.69%
Unreported/Refused to Report Race and Ethnicity 29.77% 35.87%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 174
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 35.90%
COVID-19 Immunization Series Completed 245
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 23.14%
COVID-19 Immunization Series Additional 14
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 0.00%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 43.10% 71.84% 71.43%
White, Hispanic/Latino Patients 13.79% 11.02% 0.00%
Black/African American, Non-Hispanic/Latino Patients 5.75% 4.49% 0.00%
Black/African American, Hispanic/Latino Patients 0.57% 1.22% 0.00%
Asian Patients3 2.87% 3.67% 0.00%
American Indian/Alaska Native Patients3 0.00% 0.00% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.00% 0.00%
Patients with More than one race3 1.15% 1.22% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.00% 0.00% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.72% 0.82% 0.00%
Unreported/Refused to Report Race and Ethnicity 31.03% 5.71% 28.57%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 11.11%
1 to 24 Hours 33.33%
More Than 24 Hours 55.56%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 44.44%
Vaccine confidence 22.22%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 0.00%
None 44.44%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 22.22%
Average Percent of Health Center Visits Conducted Virtually 16.11%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 11.11%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 0
Number of School-Based Vaccination Sites 1

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 55.56%
None 44.44%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 22.22%
Patient awareness/education 11.11%
Staffing capacity 11.11%
Therapy administration/onsite logistics 0.00%
Other 0.00%
None 55.56%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021